Pot topics: The DEA changes the classification of the drug based on CBD oil; LAX allows



[ad_1]

Pot Topics is a weekly cannabis news collection organized by the Chicago Sun-Times. Here are the best stories of this week:

  • A cannabis-related epilepsy drug could be on sale in the weeks following a major move by the DEA
  • Elon Musk, CEO of Tesla, used a marijuana number to determine the price of his shares? The FEC says yes.
  • A new policy allows travelers to bring grass to the Los Angeles International Airport. Can you also take it on your flight?
  • Jamaica starts shipping cannabis oil in Canada

The move from DEA to CBD oil could pave the way for new research on marijuana drug for medical purposes

<img data-attachment-id = "1040380" data-permalink = "https://chicago.suntimes.com/cannabis/marijuana-epilepsy-drug-positive-review-fda-gw-pharmaceuticals-cannabis/medical-marijuana/ "data-orig-file =" https://suntimesmedia.files.wordpress.com/2018/04/ap18107496857650.jpg?w=1024&h=770 "data-orig-size =" 1024,770 "data-comments-open = "0" data-image-meta = "{" opening ":" 2.2 "," credit ":" AP "," camera ":" iPhone SE "," legend ":" FILE – this May 23, 2017, The archive picture shows GW Pharmaceuticals u2019 Epidiolex, a drug made from the marijuana plant but without TCH. The drug has reduced seizures in children with severe epilepsy and has been approved in the United States, public health officials said Tuesday, April 17, 2018. (AP Photo / Kathy Young, File), "created_timestamp": "1495550982", "copyright": "Copyright 2018 The Associated Press. All rights reserved. "," Focal_length ":" 4.15 "," iso ":" 200 "," shutter_speed ":" 0.05 "," title ":" medical marijuana "," orientation ":" 1 "}" data- image-title = "Medical Marijuana" data-image-description = "

DOSSIER – This May 23, 2017 photo file shows Epidiolex from GW Pharmaceuticals, a drug made from the marijuana plant but without TCH. The drug has reduced seizures in children with severe epilepsy and has been approved in the United States, public health officials said Tuesday, April 17, 2018. (AP Photo / Kathy Young, File)

"data-medium-file =" https://suntimesmedia.files.wordpress.com/2018/04/ap18107496857650.jpg?w=1024&h=770?w=399 "data-large-file =" https: // suntimesmedia .files.wordpress.com / 2018/04 / ap18107496857650.jpg? w = 1024 & h = 770? w = 1024 "class =" wp-image-1040380 size-full "src =" https: //suntimesmedia.files.word. com / 2018/04 / ap18107496857650.jpg? w = 1024 & h = 770 "alt =" Epidiolex from GW Pharmaceuticals, a drug made from the marijuana plant, but without TCH. "width =" 1024 "height =" 770 "srcset =" https: //suntimesmedia.files.wordpress.com/2018/04/ap18107496857650.jpg 1024w, https://suntimesmedia.files.wordpress.com/2018/04 /ap18107496857650.jpg?w=150&h=113 150w, https: / /suntimesmedia.files.wordpress.com/2018/04/ap18107496857650.jpg?w=399&h=300 399w, https://suntimesmedia.files.wordpress.com /2018/04/ap18107496857650.jpg?w=768&h=578 768w "sizes =" (maximum width: 1024px) 100vw, 1024px "/>

The DEA has recently reprogrammed Epidiolex, the first cannabis-derived drug to gain federal approval. | AP file photo

Epidiolex, the first pot-derived drug to gain federal approval, was approved for sale Thursday when the Drug Enforcement Administration announced that it was being rescheduled in a classroom lower drug.

In June, the FDA approved Epidiolex to treat two rare forms of epilepsy in children. The strawberry syrup, developed by the British company GW Pharmaceuticals, is made from CBD, or cannabidiol, a form of non-intoxicating cannabis that reduces seizures.

The DEA downgraded Epidiolex from Appendix I – a class that includes marijuana, heroin and ecstasy – to Schedule V of the Controlled Substances Act. Unlike the more restrictive classification, drugs listed in Schedule V would pose little risk of abuse.

"With this final step in the regulatory process being competitive, we are working hard to make Epidiolex available within the next six weeks, knowing that we are excited about a standardized version of cannabidiol, subject to the rigor of controlled clinical trials and approved by the FDA. Said Justin Gover, CEO of GW Pharmaceuticals, in a statement.

Pot stocks jumped on Thursday after the DEA announced its decision. Not surprisingly, one of the biggest winners of the day was GW Pharmaceuticals, up 7%, a record high, according to CNBC.

In an interview with Business Insider on Thursday, Gover said the company was already seeking federal approval for an oromucosal-based oral spray used to treat spasticity due to multiple sclerosis. Instead of CBD, the drug uses THC, or tetrahydrocannabinol, the cannabinoid that makes users tumble.

Despite the reclassification of Epidiolex, the FDA has failed to reprogram all CBD-based products widely, as some would have expected. In a statement, the agency said that marijuana and its derivatives would remain illegal under federal law "except in the limited circumstances where it has been determined that there is a medically approved benefit". In these cases, the pot will be made available to the public. .

"The DEA will continue to support scientific and scientific research that promotes legitimate therapeutic uses of FDA-approved cannabis components, in accordance with federal law," said Uttam Dhillon, acting administrator of the DEA, in a statement. "The DEA is committed to continuing to work with our federal partners to find ways to make the research process more efficient and cost-effective."

SEC cites Musk reference in fraud lawsuit

Elon Musk, CEO of Tesla, smokes cannabis during an interview | From the Joe Rogan Experience YouTube Channel

Elon Musk, CEO of Tesla, smokes cannabis during an interview | From the Joe Rogan Experience YouTube Channel

The Securities and Exchange Commission is suing Tesla's CEO, Elon Musk, claiming that he had sent false or misleading tweets last month on securing funding to take the company's business. electric cars at $ 420 per share.

The trial circle this figure, which is usually associated with the use of the pot.

Musk proposed to take Tesla in camera in an email to members of the board of directors on Aug. 2, noting that "incessant defamatory attacks" were harming the brand, according to the lawsuit filed Thursday in the US District District Court. south of New York. Musk calculated the price of $ 420 based on a 20% premium over the closing price of the day's stock, which he considered a "standard premium" for such transactions.

However, the lawsuit claims that Musk's calculation resulted in a price of $ 419. But the troubled technical visionary rounded up the value to $ 420 because he had recently learned "the importance of the number in marijuana growing" and thought it would entertain his girlfriend, Canadian singer Grimes.

Musk then sent a series of tweets August 7 detailing his proposal. Between Musk's first tied tweet and trading close on the day, Tesla's share price rose more than 6%. The next day, Tesla shares jumped nearly 11%.

The suit, which accuses Musk of securities fraud, is seeking to ban him from sitting as an officer or director of any publicly traded company.

"Executives hold positions of trust in our markets and have significant shareholder responsibilities," said Steven Peikin, co-director of the SEC's Enforcement Division. "An agent's celebrity status or reputation as a technology innovator does not allow them to take these responsibilities lightly."

On Thursday, Musk said in a statement that he was "deeply saddened and disappointed" by the "unjustified action" of the S.E.C.

"I've always acted in the best interests of truth, transparency and investors," Musk added. "Integrity is the most important value in my life and the facts will show that I have never compromised this in any way."

Earlier this month, Musk had more trouble cooking when he seemed to blow on a joint when he appeared in The Joe Rogan Experience. As the video went viral, Tesla announced that the accounting director Dave Morton was leaving after only a month's work due to the public's attention and the speed of the work.

The company is under new pressure to generate sustained earnings starting this quarter, as Musk has promised. However, the company spent $ 739.5 million in the previous quarter and lost a quarterly record of $ 717.5 million.

Travelers can bring marijuana to LAX, but not on their flights

plane

Sun-Times file image

A new police policy at Los Angeles International Airport allows travelers to bring small amounts of marijuana to the third hub of the country's flights, but this announcement warns that small possession can still be a problem. federal crime if TSA officers detect your hiding place.

Lorie Dankers, spokeswoman for the Transportation Security Administration, said on Thursday that officers would not confiscate cannabis to travelers, but instead would call the police to fix the problem.

"The TSA focuses on terrorism and the security threats to the plane and its passengers," said Dankers. "Whether the passenger is allowed or not to travel with marijuana is at the discretion of law enforcement."

A LAX traveler found with less than an ounce of cannabis flower or 8 grams of concentrated jar will be dropped "because there is no crime," said a senior official. 39 airport. Alicia Hernandez said.

However, marijuana laws vary from state to state. For example, travelers are prohibited from providing assistance at the Denver International Airport, while Colorado legalized the drug for recreational purposes in 2012.

Due to the contradiction of the laws, Douglass Kidd, executive director of the National Association of Airline Passengers, advised travelers to leave their potty at home.

"The first thing the TSA will do is if they discover that something that is illegal for federal purposes is that they will send it back to the local police," Kidd said. "Now the local law enforcement can say," We will not do anything. "But the delay could make you miss your flight."

Jamaica sends first shipment of cannabis oil to Canada

Jamaican cdb-based petroleum products are now shipped to Canada. | Photo AP

Jamaican cdb-based petroleum products are now shipped to Canada. | Photo AP

The Jamaican authorities announced Thursday that the country has shipped its first shipment of cannabis oil to Canada.

The agreement was launched when an import permit issued by the Public Health Department of Canada was obtained on behalf of Timeless Herbal Care, a medical cannabis company based in Kingston, Jamaica. The company then obtained an export permit from the Jamaica Ministry of Health.

Since the decriminalization of marijuana in 2015, the small island country has established itself as a global center for weed control.

"Jamaica is uniquely positioned to become a global player and we are committed to providing the leadership and resources necessary to open international markets, including Canada and Europe, to our licensed and regulated Jamaican companies," he said. said Audley Shaw, Minister of Industry and Commerce of the country. , agriculture and fisheries.

Associated Press contributed to this report.

Upcoming cannabis events in the Chicago area

Sun-Times Cannabis Information Guides:

Our coverage also includes:

[ad_2]
Source link